ArticleCancers2022

Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors.

Sho Hasegawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.